“It is a critical validation step for Cynata’s ongoing commercial partnering activities.
CASH still $23.8m”
Not enough to afford the paper clips for a FDA trial.
Oh, it’s critical. No argument there!
Ongoing commercial partnering activities. Right-o!
Does anyones else think that they have no leverage to negotiate?
They are totally reliant on Ross’ negotiation skills. And any potential partner knows they haven’t got the financial resources to do the trial alone.
Let’s see how Ross does. By the end of the year.
Together we are all going to watch this unfold. I can’t wait!
Go, Ross!!
- Forums
- ASX - By Stock
- CYP
- Ann: Quarterly Activity Report & Appendix 4C
CYP
cynata therapeutics limited
Add to My Watchlist
13.3%
!
17.0¢

Ann: Quarterly Activity Report & Appendix 4C, page-9
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
17.0¢ |
Change
0.020(13.3%) |
Mkt cap ! $38.41M |
Open | High | Low | Value | Volume |
16.0¢ | 17.0¢ | 15.0¢ | $44.58K | 285.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3114 | 16.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.0¢ | 69999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3114 | 0.160 |
4 | 46158 | 0.150 |
3 | 110000 | 0.145 |
2 | 45000 | 0.140 |
2 | 105000 | 0.130 |
Price($) | Vol. | No. |
---|---|---|
0.170 | 69999 | 1 |
0.180 | 76583 | 2 |
0.185 | 35990 | 1 |
0.195 | 2650 | 1 |
0.200 | 46400 | 2 |
Last trade - 16.10pm 01/07/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Dr. Steven Gourlay, CEO
Dr. Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online